FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

11429411000001101: Cabergoline 4mg tablets (Teva UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
41048601000001119 Cabergoline 4mg tablets (Teva UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
41048701000001112 Cabergoline 4mg tablets (Teva UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cabergoline 4mg tablets (Teva UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Cabergoline 4mg tablets (Teva UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Cabergoline 4mg tablets (Teva UK Ltd) Is a Product containing precisely cabergoline 4 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Cabergoline 4mg tablets (Teva UK Ltd) Has active ingredient Cabergoline false Inferred relationship Existential restriction modifier
Cabergoline 4mg tablets (Teva UK Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Cabergoline 4mg tablets (Teva UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Cabergoline 4mg tablets (Teva UK Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Cabergoline 4mg tablets (Teva UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Cabergoline 4mg tablets (Teva UK Ltd) Has specific active ingredient Cabergoline true Inferred relationship Existential restriction modifier
Cabergoline 4mg tablets (Teva UK Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Cabergoline 4mg tablets (Teva UK Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Cabergoline 4mg tablets (Teva UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Cabergoline 4mg tablets (Teva UK Ltd) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Cabergoline 4mg tablets (Teva UK Ltd) 16 tablet Is pack of False Cabergoline 4mg tablets (Teva UK Ltd) Inferred relationship Existential restriction modifier
Cabergoline 4mg tablets (Teva UK Ltd) 16 tablet Has AMP True Cabergoline 4mg tablets (Teva UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start